(Q47790377)
Statements
1 reference
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers (English)
1 reference
Barbara White
1 reference
Francisco Leon
1 reference
Wendy White
1 reference
Gabriel Robbie
1 reference
1 April 2009
1 reference
31
1 reference
4
1 reference
728-740
1 reference